Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,792,516
+$3,474,703 QoQ
Shares Held
161,903
+3.4% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#106
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,401 across 216 Biotechnology names. CYTK ranks #36 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in CYTK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,792,516 | 161,903 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $10,317,813 | 156,544 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $15,054,212 | 236,925 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $28,210,417 | 513,290 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $11,489,295 | 347,739 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $803,557 | 19,994 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $1,564,220 | 33,253 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,972,449 | 37,357 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $1,809,665 | 33,401 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $2,119,635 | 30,233 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,313,507 | 27,710 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $865,505 | 29,379 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,117,920 | 34,271 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,397,113 | 39,702 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,907,211 | 41,624 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,977,341 | 40,812 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,499,895 | 38,175 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,358,583 | 36,908 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,657,516 | 36,365 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $362,224 | 10,135 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $200,571 | 10,135 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $366,973 | 15,777 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $340,397 | 16,381 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $428,172 | 19,777 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $492,377 | 20,890 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $255,359 | 21,659 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||